Overall incidence of prostate cancer decreased between 2003 and 2017.
There is evidence to support the role of metastasectomy in providing patients with mRCC an improvement in certain clinical outcomes.
Hemodialysis was found to be a poor prognostic factor for patients with RCC.
There was a small beneficial effect of adding docetaxel to androgen suppression and radiotherapy, a follow-up study showed.
Validated PROMs can assist in providing high-quality care and improve a patient’s overall experience.
MRI-guided TULSA uses a transurethral catheter to precisely apply ultrasound and MRI-guided thermotherapy to ablate cancerous tissue within the prostate gland.
Heterogeneity in protocols across centers has contributed to a lack of long-term outcomes for different active surveillance protocols.
The microbiome could have a role in the diagnosis of PrCa.
